# IONIS PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/ionis-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 14 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:37.386881+00:00 | | Last reviewed | 2026-10-17T04:45:37.386881+00:00 | ## Identity - Legal name: IONIS PHARMACEUTICALS INC - Display name: IONIS PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T09:44:42.354652+00:00 | | Completeness | 0.409 | | Record Quality | 0.845 | | Directors | 2 | | Committees | 1 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Joan E. Herman: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:6 - Spencer R. Berthelsen: Director. Status: current. Independent: true. Since: 2002-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:7 ## Committees - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Joan E. Herman (member, current); Spencer R. Berthelsen (member, current). committee_id=alpha:committee:ionis-pharmaceuticals-inc:compensation ## Executive leadership - Brett P. Monia: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:8 - Brian Birchler: Executive Vice President, Corporate Development and Operations. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:9 - C. Frank Bennett: Executive Vice President, Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:10 - Elizabeth L. Hougen: Executive Vice President, Finance and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:11 - Eric E. Swayze: Executive Vice President, Research. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:12 - Eugene Schneider: Executive Vice President, Chief Clinical Development and Operations Officer. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:13 - Holly Kordasiewicz: Executive Vice President, Chief Development Officer. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:14 - Joseph T. Baroldi: Executive Vice President, Chief Business Officer. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:15 - Kyle Jenne: Executive Vice President, Chief Global Product Strategy Officer. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:16 - Patrick R. O Neil: Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:17 - Shannon L. Devers: Executive Vice President, Chief Human Resources Officer [CHRO]. Status: current. claim_id=alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:18 ## Governance events - CEO_CHANGED: Brett P. Monia executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:eckqp1mopqtf - EXECUTIVE_APPOINTED: Brian Birchler executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1fp4uh71m76kb - EXECUTIVE_APPOINTED: C. Frank Bennett executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:89ikae4dmyuc - CFO_CHANGED: Elizabeth L. Hougen executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:liznjx5hv0tf - EXECUTIVE_APPOINTED: Eric E. Swayze executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:laq1dvep5vbd - EXECUTIVE_APPOINTED: Eugene Schneider executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:l1m7zpjpq44x - EXECUTIVE_APPOINTED: Holly Kordasiewicz executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1lcil21du8awt - EXECUTIVE_APPOINTED: Joseph T. Baroldi executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:12elhbp1sxslh7 - EXECUTIVE_APPOINTED: Kyle Jenne executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1vzah351y9tbu9 - GC_CHANGED: Patrick R. O Neil executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:14629ccqdvkgg - EXECUTIVE_APPOINTED: Shannon L. Devers executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1am1grf7nkg43 - DIRECTOR_APPOINTED: Joan E. Herman seat on IONIS PHARMACEUTICALS INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1vgvw1p1a6ret5 - COMMITTEE_MEMBER_ADDED: Joan E. Herman member of Compensation, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:g2y5qerbpwbg - DIRECTOR_APPOINTED: Spencer R. Berthelsen seat on IONIS PHARMACEUTICALS INC, effective 2002-01-01. Effective: 2002-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:17misjwu7os1i ## Scoped resources - `alpha://company/ionis-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record - `alpha://company/ionis-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/ionis-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/ionis-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=board - `alpha://company/ionis-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/ionis-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/ionis-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/ionis-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/ionis-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/ionis-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/ionis-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/ionis-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/ionis-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/ionis-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/ionis-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/ionis-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/ionis-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/ionis-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/ionis-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/ionis-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=events - `alpha://company/ionis-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/ionis-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/ionis-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:joan-e-herman","name":"Joan E. Herman"},"source_id":"board_seats"}` - Claim alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:spencer-r-berthelsen","name":"Spencer R. Berthelsen"},"source_id":"board_seats"}` ## Leadership - Joan E. Herman: Director, Compensation. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:6. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b9f6a7411d44c1aa4fa09093d959ebf1b50fbb64c23ffb89a526dc9dfb08464. - Spencer R. Berthelsen: Director, Compensation. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:7. Valid from: 2002-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b9f6a7411d44c1aa4fa09093d959ebf1b50fbb64c23ffb89a526dc9dfb08464. - Brett P. Monia: Chief Executive Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:8. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:49a71ce8bbffb84853586868d47cbc3e77adc02650d82db945180c0d50dcab42. - Brian Birchler: Executive Vice President, Corporate Development and Operations. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:9. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8878d4a5960ec580beffcc484bd84c83ce1c926f639f742368035874ac238f39. - C. Frank Bennett: Executive Vice President, Chief Scientific Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:10. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:47e558adea11e378b979447f63aec41c7199f29a4065b8ebc0df83acc7255c81. - Elizabeth L. Hougen: Executive Vice President, Finance and Chief Financial Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:11. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dcb41d0451de496b35df284812771020df8fe78f5360bf95635657d4b916d6b2. - Eric E. Swayze: Executive Vice President, Research. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:12. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3ebb466a25fae76f35f4bd8f50c25f90a075b15dd38861ab88788b8cb638897c. - Eugene Schneider: Executive Vice President, Chief Clinical Development and Operations Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:13. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d1fc57a8f0c33dd4ca416b305f1ffce040f3cec171ad77044fe14022d7f94170. - Holly Kordasiewicz: Executive Vice President, Chief Development Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:14. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9289d9763172eecb33bdc233bb32eef61c15c1946190988644353c27aac34c3b. - Joseph T. Baroldi: Executive Vice President, Chief Business Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:15. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:be01d22c377a6a0ef600b97130ac6dd50109e0472e20508934f383c4f0332e06. - Kyle Jenne: Executive Vice President, Chief Global Product Strategy Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:16. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:38b0865b15381b1f4ab80f6a0066a7f1015642bb96d11dcda3113aadd19018ad. - Patrick R. O Neil: Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:17. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1c930cd5fa03c976e5b0c0859b19f6fdd5c8195dea9f2a9323a1bd932575e760. - Shannon L. Devers: Executive Vice President, Chief Human Resources Officer. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:18. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2f2335db39a49b2fbf2f6a0193ee296cea27d8a0b3e067ecc976fb83ae572247. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Compensation: Chair not stated; Members Joan E. Herman; Spencer R. Berthelsen. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42281f3c82ba1c74895b3aadafaa8e662e74170a01e38703d41bec8afac6586. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - IONIS PHARMACEUTICALS INC. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14595143841161a6dea932206e8fa943ff5e03fecb5872f2be6e1ae78e91a808. ## Entity Status - Public listing published. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14595143841161a6dea932206e8fa943ff5e03fecb5872f2be6e1ae78e91a808. ## Published Fact - US. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14595143841161a6dea932206e8fa943ff5e03fecb5872f2be6e1ae78e91a808. - Healthcare. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14595143841161a6dea932206e8fa943ff5e03fecb5872f2be6e1ae78e91a808. ## Committee Appointment - Joan E. Herman: member, Compensation. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42281f3c82ba1c74895b3aadafaa8e662e74170a01e38703d41bec8afac6586. - Spencer R. Berthelsen: member, Compensation. Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e42281f3c82ba1c74895b3aadafaa8e662e74170a01e38703d41bec8afac6586. ## Security Listing - IONS (NASDAQ). Claim: alpha:claim:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14595143841161a6dea932206e8fa943ff5e03fecb5872f2be6e1ae78e91a808. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:14595143841161a6dea932206e8fa943ff5e03fecb5872f2be6e1ae78e91a808: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc). - alpha:projection-evidence:document:9b9f6a7411d44c1aa4fa09093d959ebf1b50fbb64c23ffb89a526dc9dfb08464: [Ionis Pharmaceuticals DEF 14A 2026-04-23](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:49a71ce8bbffb84853586868d47cbc3e77adc02650d82db945180c0d50dcab42: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:8878d4a5960ec580beffcc484bd84c83ce1c926f639f742368035874ac238f39: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:47e558adea11e378b979447f63aec41c7199f29a4065b8ebc0df83acc7255c81: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:dcb41d0451de496b35df284812771020df8fe78f5360bf95635657d4b916d6b2: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:3ebb466a25fae76f35f4bd8f50c25f90a075b15dd38861ab88788b8cb638897c: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:d1fc57a8f0c33dd4ca416b305f1ffce040f3cec171ad77044fe14022d7f94170: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:9289d9763172eecb33bdc233bb32eef61c15c1946190988644353c27aac34c3b: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:be01d22c377a6a0ef600b97130ac6dd50109e0472e20508934f383c4f0332e06: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:38b0865b15381b1f4ab80f6a0066a7f1015642bb96d11dcda3113aadd19018ad: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:1c930cd5fa03c976e5b0c0859b19f6fdd5c8195dea9f2a9323a1bd932575e760: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:document:2f2335db39a49b2fbf2f6a0193ee296cea27d8a0b3e067ecc976fb83ae572247: [IONS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). - alpha:projection-evidence:e42281f3c82ba1c74895b3aadafaa8e662e74170a01e38703d41bec8afac6586: [Compensation](https://www.sec.gov/Archives/edgar/data/874015/000114036126016388/ny20063671x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/ionis-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/ionis-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/ionis-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/ionis-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T09:44:42.150816+00:00; recorded 2026-10-17T09:44:42.150816+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.